Seven Cornell research teams have received grants to advance early-stage life science technologies with biotechnology companies across New York, the university announced.
The projects began July 1 and carry more than $1.2 million in combined support, including $562,258 from Empire State Development's NYSTAR program and $643,000 in matching contributions from industry partners.
The projects span treatments for herniated spinal discs, fertility care, artificial intelligence for eye-disease screening, reduced childhood antibiotic use and frost protection for crops.
Cornell's Center for Advanced Technology awards investigators up to $75,000, matched dollar for dollar by participating companies, for research with commercial potential.
University officials said the partnerships are intended to move laboratory discoveries toward practical uses while strengthening New York's life sciences sector.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to news@fingerlakes1.com.